The findings suggest that mild or moderate Covid-19 may accelerate biological processes that contribute to the buildup of ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

For years, scientists have focused on amyloid beta buildup as the main culprit in Alzheimer’s disease, but a new study suggests the real problem might lie in a stalled protein-cutting process in the ...

Researchers have demonstrated that individuals who had childhood epilepsy have an increased accumulation of brain amyloid ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.